Decisive Study Validates Roche's cobas HPV Test for Identifying Women at Highest Risk for Cervical Cancer

Jacobs, Rodger
April 2011
Clinical Lab Products;Apr2011, Vol. 41 Issue 4, p8
Trade Publication
The article discusses the study "Addressing the Need for Advanced HPV Diagnostics (ATHENA)" that highlights the potential of the cobas HPV Test in detecting the presence of HPV-16 and HPV-18, and identifies cervical pre-cancer missed by traditional Pap test. The study, funded by Roche Molecular Systems, involved women with atypical squamous cells of undetermined significance (ASC-US). The cobas HPV Test is under review and pending Pre-Market approval by the Food and Drug Administration (FDA).


Related Articles

  • FDA letter causes hurdle in GT's plan for LuViva U.S. approval. Ford, Omar // Medical Device Daily;1/24/2012, Vol. 16 Issue 15, p1 

    The article reports that a not approvable letter from the U.S. Food and Drug Administration (FDA) has been received by Guided Therapeutics for its LuViva device. The device scans the cervix with light to identify cancer and pre-cancer lesions in a painless and non-invasive manner. It relates the...

  • FDA approves GeneSearch to detect breast cancer.  // Medical Technology & Devices Week;7/23/2007, Vol. 5 Issue 30, p4 

    The article announces that the U.S. Food & Drug Administration (FDA) approved the GeneSearch Breast Lymph Node (BLN) Assay from Veridex. The assay is designed to detect the spread of cancer into the lymph nodes more accurately than existing rapid methodologies, according to the firm. It is said...

  • Health Monitor. Chen, Joanne // Marie Claire (US Edition);Jul2009, Vol. 16 Issue 7, p154 

    The article offers information on several issues related to health. After consuming the food that has just been recalled, it suggests to avoid strenuous schedule for the next 72 hours and to drink lots of fluids. It mentions specific burgers as per the body types including soy patties for apple...

  • Among the elite.  // Business News New Jersey;11/13/96, Vol. 9 Issue 23, p3 

    Reports that biotechnology firm Cytogen has obtained United States Food & Drug Administration approval to market its ProstaScint, a monoclonal, antibody-based imaging agent for the diagnosis of prostate cancer.

  • AMDL launches diagnostics branch to focus on Onko-Sure.  // Medical Device Daily;8/21/2009, Vol. 13 Issue 161, p4 

    The article reports on the launching of AMDL Diagnostics (ADI), a subsidiary of AMDL that will focus on the research, development, manufacture and international sales of Onko-Sure AMDL's proprietary, regulatory approved in vitro diagnostic (IVD) cancer test. It explains the purpose of...

  • Trimira's Identafi 3000 ramps up oral cancer screenings. YOFFEE, LYNN // Medical Device Daily;12/22/2009, Vol. 13 Issue 245, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) has given approval to Trimira for its Identafi 3000 oral cancer detection device. Aside from being diagnostic tool for cancer, the multispectral fluorescence and reflectance optical system is also being developed to replace Pap...

  • Guided Therapeutics seeks PMA to find cancer via light. PEDERSEN, AMANDA // Medical Device Daily;9/28/2010, Vol. 14 Issue 188, p1 

    The article reports on a premarket approval application (PMA) filed by Guided Therapeutics with the U.S. Food and Drug Administration for its LightTouch cervical cancer scanner for patients at risk for cervical cancer. The company compared the effectiveness of its product with other current...

  • Biomoda gets U.S. patent for cancer assay technology.  // Medical Device Daily;11/6/2009, Vol. 13 Issue 215, p9 

    The article reports that Biomoda in Albuquerque, New Mexico, has received a notice of allowance for a U.S. patent that protects the proprietary formula for its cancer assay technology. Biomoda President John Cousins said that the patent gives the company a lock on the composition for the...

  • FDA Panel Recommends Approval for U-Systems' Breast Cancer Screening Tool for Women with Dense Breasts.  // Biomedical Market Newsletter;4/14/2012, Vol. 21, p1 

    The article informs that the U.S. Food & Drug Administration (FDA) Radiological Devices Panel of the Medical Devices Advisory Committee has recommended approval for somo'v Automated Breast Ultrasound (ABUS) system from U-Systems Inc. The somo'v ABUS system is currently FDA-cleared for diagnostic...

  • Product briefs.  // Biomedical Business & Technology;Nov2008, Vol. 31 Issue 11, p35 

    This article reports on the approval received by Roche Molecular Diagnostics from the U.S. Food and Drug Administration (FDA) for its Roche Cobas TaqMan HBV Test, the first assay for quantitating hepatitis B virus deoxyribonucleic acid (DNA). Real-time polymerase chain reaction (PCR) technology...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics